ANTIDIABETIC REMEDY

FIELD: medicine.SUBSTANCE: invention relates to medicine, namely pharmacology, and concerns the use of 2-[(1,1'-biphenyl)-4-yl]imidazo[2,1-a]isoquinoline of formula I:, as a compound exhibiting both AMPA-activating and PTP1B-inhibitory action.EFFECT: proposed antidiabetic means.1 cl, 2 dwg, 2 e...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Babkov Denis Aleksandrovich, Zhukovskaya Olga Nikolaevna, Spasov Aleksandr Alekseevich, Kuzmenko Tatyana Andreevna, Morkovnik Anatolij Savelevich, Brigadirova Anastasiya Andreevna
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine.SUBSTANCE: invention relates to medicine, namely pharmacology, and concerns the use of 2-[(1,1'-biphenyl)-4-yl]imidazo[2,1-a]isoquinoline of formula I:, as a compound exhibiting both AMPA-activating and PTP1B-inhibitory action.EFFECT: proposed antidiabetic means.1 cl, 2 dwg, 2 ex, 1 tbl Изобретение относится к медицине, а именно к фармакологии, и касается применения 2-[(1,1'-бифенил)-4-ил]имидазо[2,1-а]изохинолина формулы I:в качестве соединения, проявляющего одновременно АМРК-активирующее и PTP1B-ингибирующее действие. 1 з.п. ф-лы, 2 ил., 2 пр., 1 табл.